Pulmonx Corp Stock Gross Profit

LUNG Stock

USD 1.61 0.23 12.50%

Fundamental analysis of Pulmonx Corp allows traders to better anticipate movements in Pulmonx Corp's stock price by examining its financial health and performance throughout various phases of its business cycle.

	Last Reported	Projected for Next Year
Gross Profit	62 M	65.1 M
Gross Profit Margin	0.74	0.56

The Pulmonx Corp's current Gross Profit is estimated to increase to about 65.1 M, while Gross Profit Margin is projected to decrease to 0.56.

Build AI portfolio with Pulmonx Stock

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Pulmonx Corp Company Gross Profit Analysis

Pulmonx Corp's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current Pulmonx Corp Gross Profit

66.16 M

Most of Pulmonx Corp's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pulmonx Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Pulmonx Gross Profit Driver Correlations

Understanding the fundamental principles of building solid financial models for Pulmonx Corp is extremely important. It helps to project a fair market value of Pulmonx Stock properly, considering its historical fundamentals such as Gross Profit. Since Pulmonx Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pulmonx Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pulmonx Corp's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Long Term Debt	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Net Receivables	Intangible Assets	Current Deferred Revenue	Net Debt	Good Will	Net Invested Capital	Capital Stock	Net Working Capital	Deferred Long Term Liab	Long Term Debt Total	Capital Surpluse
Total Assets		0.78	0.78	-0.79	0.55	0.6	0.15	0.03	1.0	0.8	0.88	0.9	0.69	-0.04	-0.48	-0.93	-0.17	0.97	0.93	0.98	-0.93	0.6	0.47
Total Stockholder Equity	0.78		0.97	-0.46	0.2	0.21	-0.49	0.17	0.8	0.73	0.67	0.57	0.4	-0.49	-0.61	-0.78	-0.19	0.87	0.77	0.83	-0.81	0.48	0.37
Net Tangible Assets	0.78	0.97		-0.6	0.38	0.36	-0.41	0.37	0.78	0.75	0.71	0.56	0.52	-0.57	-0.63	-0.71	-0.4	0.89	0.84	0.83	-0.87	0.65	0.57
Retained Earnings	-0.79	-0.46	-0.6		-0.89	-0.91	-0.43	-0.41	-0.76	-0.72	-0.81	-0.68	-0.91	0.14	0.37	0.54	0.58	-0.8	-0.91	-0.76	0.89	-0.85	-0.8
Accounts Payable	0.55	0.2	0.38	-0.89		0.82	0.56	0.43	0.53	0.41	0.56	0.58	0.78	-0.06	-0.18	-0.33	-0.76	0.55	0.7	0.56	-0.68	0.79	0.81
Long Term Debt	0.6	0.21	0.36	-0.91	0.82		0.57	0.39	0.57	0.53	0.65	0.5	0.81	0.06	-0.36	-0.37	-0.56	0.62	0.73	0.58	-0.71	0.71	0.7
Total Liab	0.15	-0.49	-0.41	-0.43	0.56	0.57		-0.12	0.13	-0.04	0.17	0.35	0.36	0.67	0.25	-0.04	-0.11	-0.01	0.11	0.08	-0.06	0.12	0.13
Short Long Term Debt	0.03	0.17	0.37	-0.41	0.43	0.39	-0.12		0.01	0.27	0.29	-0.1	0.33	-0.64	-0.25	0.18	-0.73	0.17	0.33	0.08	-0.31	0.61	0.71
Total Current Assets	1.0	0.8	0.78	-0.76	0.53	0.57	0.13	0.01		0.79	0.87	0.9	0.65	-0.02	-0.51	-0.95	-0.16	0.97	0.91	0.98	-0.92	0.56	0.44
Short Term Debt	0.8	0.73	0.75	-0.72	0.41	0.53	-0.04	0.27	0.79		0.83	0.52	0.65	-0.32	-0.62	-0.67	-0.18	0.84	0.86	0.77	-0.84	0.61	0.55
Common Stock	0.88	0.67	0.71	-0.81	0.56	0.65	0.17	0.29	0.87	0.83		0.74	0.72	-0.16	-0.4	-0.72	-0.25	0.88	0.9	0.84	-0.88	0.71	0.61
Property Plant Equipment	0.9	0.57	0.56	-0.68	0.58	0.5	0.35	-0.1	0.9	0.52	0.74		0.58	0.17	-0.17	-0.86	-0.13	0.8	0.77	0.88	-0.78	0.47	0.33
Net Receivables	0.69	0.4	0.52	-0.91	0.78	0.81	0.36	0.33	0.65	0.65	0.72	0.58		-0.27	-0.25	-0.4	-0.42	0.69	0.84	0.61	-0.78	0.85	0.8
Intangible Assets	-0.04	-0.49	-0.57	0.14	-0.06	0.06	0.67	-0.64	-0.02	-0.32	-0.16	0.17	-0.27		0.24	-0.13	0.4	-0.21	-0.3	-0.07	0.29	-0.48	-0.5
Current Deferred Revenue	-0.48	-0.61	-0.63	0.37	-0.18	-0.36	0.25	-0.25	-0.51	-0.62	-0.4	-0.17	-0.25	0.24		0.55	0.29	-0.58	-0.5	-0.57	0.55	-0.17	-0.23
Net Debt	-0.93	-0.78	-0.71	0.54	-0.33	-0.37	-0.04	0.18	-0.95	-0.67	-0.72	-0.86	-0.4	-0.13	0.55		0.01	-0.88	-0.75	-0.94	0.78	-0.29	-0.17
Good Will	-0.17	-0.19	-0.4	0.58	-0.76	-0.56	-0.11	-0.73	-0.16	-0.18	-0.25	-0.13	-0.42	0.4	0.29	0.01		-0.3	-0.44	-0.29	0.46	-0.66	-0.75
Net Invested Capital	0.97	0.87	0.89	-0.8	0.55	0.62	-0.01	0.17	0.97	0.84	0.88	0.8	0.69	-0.21	-0.58	-0.88	-0.3		0.96	0.98	-0.98	0.67	0.55
Capital Stock	0.93	0.77	0.84	-0.91	0.7	0.73	0.11	0.33	0.91	0.86	0.9	0.77	0.84	-0.3	-0.5	-0.75	-0.44	0.96		0.92	-0.99	0.82	0.73
Net Working Capital	0.98	0.83	0.83	-0.76	0.56	0.58	0.08	0.08	0.98	0.77	0.84	0.88	0.61	-0.07	-0.57	-0.94	-0.29	0.98	0.92		-0.94	0.56	0.45
Deferred Long Term Liab	-0.93	-0.81	-0.87	0.89	-0.68	-0.71	-0.06	-0.31	-0.92	-0.84	-0.88	-0.78	-0.78	0.29	0.55	0.78	0.46	-0.98	-0.99	-0.94		-0.78	-0.69
Long Term Debt Total	0.6	0.48	0.65	-0.85	0.79	0.71	0.12	0.61	0.56	0.61	0.71	0.47	0.85	-0.48	-0.17	-0.29	-0.66	0.67	0.82	0.56	-0.78		0.97
Capital Surpluse	0.47	0.37	0.57	-0.8	0.81	0.7	0.13	0.71	0.44	0.55	0.61	0.33	0.8	-0.5	-0.23	-0.17	-0.75	0.55	0.73	0.45	-0.69	0.97

Click cells to compare fundamentals

Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

Competition

Predict Pulmonx Corp

Gross Profit Over Time

According to the company disclosure, Pulmonx Corp reported 66.16 M of gross profit. This is 97.05% lower than that of the Health Care Equipment & Supplies sector and 95.9% lower than that of the Health Care industry. The gross profit for all United States stocks is 99.76% higher than that of the company.

Pulmonx Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pulmonx Corp's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pulmonx Corp could also be used in its relative valuation, which is a method of valuing Pulmonx Corp by comparing valuation metrics of similar companies.

Pulmonx Corp is currently under evaluation in gross profit category among its peers.

Pulmonx Corp Current Valuation Drivers

We derive many important indicators used in calculating different scores of Pulmonx Corp from analyzing Pulmonx Corp's financial statements. These drivers represent accounts that assess Pulmonx Corp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Pulmonx Corp's important valuation drivers and their relationship over time.

	2020	2021	2022	2023	2024	2025 (projected)
Market Cap	2.5B	1.2B	312.7M	484.2M	556.8M	529.0M
Enterprise Value	2.3B	1.0B	235.4M	442.1M	508.4M	482.9M

Pulmonx Fundamentals

	Return On Equity	-0.67
	Return On Asset	-0.22
	Profit Margin	(0.63) %
	Operating Margin	(0.62) %
	Current Valuation	36.81 M
	Shares Outstanding	40.26 M
	Shares Owned By Insiders	4.40 %
	Shares Owned By Institutions	92.12 %
	Number Of Shares Shorted	1.44 M
	Price To Book	0.93 X
	Price To Sales	0.73 X
	Revenue	83.79 M
	Gross Profit	66.16 M
	EBITDA	(50.79 M)
	Net Income	(56.39 M)
	Cash And Equivalents	162.09 M
	Cash Per Share	4.35 X
	Total Debt	56.47 M
	Debt To Equity	0.15 %
	Current Ratio	9.43 X
	Book Value Per Share	1.70 X
	Cash Flow From Operations	(31.54 M)
	Short Ratio	4.35 X
	Earnings Per Share	(1.43) X
	Price To Earnings To Growth	(0.42) X
	Target Price	6.75
	Number Of Employees	291
	Beta	0.45
	Market Capitalization	66.22 M
	Total Asset	162.85 M
	Retained Earnings	(467.56 M)
	Working Capital	111.81 M
	Net Asset	162.85 M

About Pulmonx Corp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Pulmonx Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pulmonx Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pulmonx Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

USOI	Credit Suisse X Links
ULTY	Tidal Trust II
CONY	YieldMax N Option
BCAT	BlackRock Capital Allocation
PDI	Pimco Dynamic Income

When determining whether Pulmonx Corp is a strong investment it is important to analyze Pulmonx Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmonx Corp's future performance. For an informed investment choice regarding Pulmonx Stock, refer to the following important reports:

How To Invest In Pulmonx

Details

Is Pulmonx Stock a good investment?

Details

What is Pulmonx Corp's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Pulmonx Corp Piotroski F Score and Pulmonx Corp Altman Z Score analysis.

For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.

You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.43)

Revenue Per Share

2.274

Quarterly Revenue Growth

0.148

Return On Assets

(0.22)

Return On Equity

(0.67)

The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Pulmonx Corp Stock Gross Profit

Pulmonx Corp Company Gross Profit Analysis

Gross Profit

Revenue

-

Cost of Revenue

Current Pulmonx Corp Gross Profit

Pulmonx Gross Profit Driver Correlations

Pulmonx Gross Profit Peer Comparison

Pulmonx Corp Current Valuation Drivers

Pulmonx Fundamentals

About Pulmonx Corp Fundamental Analysis

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY